Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin P Grobusch

Showing results (21-30 of 491) with videos related to

Pageof 50
Sort By:
Travel Medicine and Infectious Disease|November 7, 2022
New recommendation on yellow fever booster vaccination in GermanyFrieder Schaumburg, Franziska Schuler, Martin P Grobusch
Travel Medicine and Infectious Disease|February 12, 2020
Coronavirus 2019-nCoV: Is the genie already out of the bottle?Thomas Hanscheid, Emília Valadas, Martin P Grobusch
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 14, 2019
Where do Eritrean migrants get infected with malaria? The importance of considering the migration routePhilippe Gautret, Martin P Grobusch, Patricia Schlagenhauf
Travel Medicine and Infectious Disease|November 8, 2021
NO TIME TO DIE ? Could pre-travel health advice help Bond to live another day?Patricia Schlagenhauf, Dipti Patel, Martin P Grobusch
Journal of Travel Medicine|May 22, 2003
Gnathostomiasis without eosinophilia led to a 5-year delay in diagnosisHortense Slevogt, Martin P Grobusch, Norbert Suttorp
Travel Medicine and Infectious Disease|November 24, 2019
Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure?Thomas Hanscheid, Patricia Schlagenhauf, Martin P Grobusch
Journal of Travel Medicine|April 28, 2004
Is quartan malaria safely prevented by mefloquine prophylaxis?Martin P Grobusch, Klaus Göbels, Dieter Teichmann
The Lancet. Infectious Diseases|September 26, 2014
Point-of-care tests: where is the point?Thomas Hänscheid, Maria Rebelo, Martin P Grobusch
Tropical Diseases, Travel Medicine and Vaccines|January 14, 2024
Monoclonal antibody applications in travel medicineHanna K de Jong, Martin P Grobusch
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 14, 2025
Re: 'Comparing Large Language Models for antibiotic prescribing in different clinical scenarios' by De Vito et alThomas Hänscheid, João Carrasco, Martin P Grobusch
Pageof 50

Showing results (21-30 of 491) with videos related to

Sort By:
Pageof 50
Travel Medicine and Infectious Disease|November 7, 2022
New recommendation on yellow fever booster vaccination in GermanyFrieder Schaumburg, Franziska Schuler, Martin P Grobusch
Travel Medicine and Infectious Disease|February 12, 2020
Coronavirus 2019-nCoV: Is the genie already out of the bottle?Thomas Hanscheid, Emília Valadas, Martin P Grobusch
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 14, 2019
Where do Eritrean migrants get infected with malaria? The importance of considering the migration routePhilippe Gautret, Martin P Grobusch, Patricia Schlagenhauf
Travel Medicine and Infectious Disease|November 8, 2021
NO TIME TO DIE ? Could pre-travel health advice help Bond to live another day?Patricia Schlagenhauf, Dipti Patel, Martin P Grobusch
Journal of Travel Medicine|May 22, 2003
Gnathostomiasis without eosinophilia led to a 5-year delay in diagnosisHortense Slevogt, Martin P Grobusch, Norbert Suttorp
Travel Medicine and Infectious Disease|November 24, 2019
Atovaquone/proguanil for malaria chemoprophylaxis - Could a difference in susceptibility during hepatic development explain the need to continue drug intake for 7 days post-exposure?Thomas Hanscheid, Patricia Schlagenhauf, Martin P Grobusch
Journal of Travel Medicine|April 28, 2004
Is quartan malaria safely prevented by mefloquine prophylaxis?Martin P Grobusch, Klaus Göbels, Dieter Teichmann
The Lancet. Infectious Diseases|September 26, 2014
Point-of-care tests: where is the point?Thomas Hänscheid, Maria Rebelo, Martin P Grobusch
Tropical Diseases, Travel Medicine and Vaccines|January 14, 2024
Monoclonal antibody applications in travel medicineHanna K de Jong, Martin P Grobusch
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 14, 2025
Re: 'Comparing Large Language Models for antibiotic prescribing in different clinical scenarios' by De Vito et alThomas Hänscheid, João Carrasco, Martin P Grobusch
Pageof 50